8-K - CNS Pharmaceuticals, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

CNS Pharmaceuticals, Inc. furnished Item 7.01 disclosing a Presentation dated March 2026 as Exhibit 99.1. This information is not filed for purposes of the Securities Exchange Act of 1934.

Key Takeaways

1Item 7.01 furnished, not filed

2Exhibit 99.1: Presentation dated March 2026

3Exhibit 104: Cover Page Interactive Data File

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

of this Current Report on Form 8-K is being furnished and shall not be “filed” for the purpose of the Securities Exchange Act of 1934, as amended (“Exchange Act

Regulation Fd

9.01

. Financial Statements and Exhibits. (d) Exhibits. No. Description 99.1 Presentation dated March 2026 104 Cover Page Interactive Data File (embedded within the

Exhibits Only

Source Document

Exhibits (2)

8-K

CURRENT REPORT

99.1

INVESTOR PRESENTATION